AKTS · Aktis Oncology, Inc.
$24.01
-0.80 (-3.22%)
At close · Jul 23
Market Cap
$1.33B
Shares
55.28M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-04-16 | 2026-04-15 | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-01-12 | — |
Showing 1–9 of 9 filings
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
11 filings
11 filers
Visit website
Investor relations